Anglin Robert M 4
4 · ROCHESTER MEDICAL CORPORATION · Filed Mar 4, 2013
Insider Transaction Report
Form 4
Anglin Robert M
VP Quality & Regulatory
Transactions
- Exercise/Conversion
Common Stock
2013-03-01$4.63/sh+4,000$18,500→ 14,600 total - Exercise/Conversion
Stock Option (Right to Buy)
2013-03-01−4,000→ 0 totalExercise: $4.63Exp: 2014-01-02→ Common Stock (4,000 underlying) - Sale
Common Stock
2013-03-01$14.70/sh−4,000$58,800→ 10,600 total
Holdings
- 5,000
Stock Option (Right to Buy)
Exercise: $10.89From: 2009-02-12Exp: 2018-02-12→ Common Stock (5,000 underlying) - 10,000
Stock Option (Right to Buy)
Exercise: $12.27From: 2011-01-28Exp: 2020-01-28→ Common Stock (10,000 underlying) - 10,000
Stock Option (Right to Buy)
Exercise: $11.91From: 2007-11-29Exp: 2016-11-29→ Common Stock (10,000 underlying) - 20,000
Stock Option (Right to Buy)
Exercise: $11.27From: 2010-02-03Exp: 2019-02-03→ Common Stock (20,000 underlying) - 10,000
Stock Option (Right to Buy)
Exercise: $10.72From: 2012-01-27Exp: 2021-01-27→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]Vest as to 25% annual cumulative installments beginning one year from date of grant, beginning the date shown.